SCHEMBL4571018

SCHEMBL4571018

CN1c2ccccc2Nc2ccccc2N(C)c2ccccc21

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 4/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
BRPF1 P55201 1/20 0.48
MAOA P21397 2/20 0.44
KMT2A Q03164 2/20 0.42
AKT1 P31749 1/20 0.42
BRD4 O60885 2/20 0.40
CHEK1 O14757 1/20 0.39
MAPT P10636 2/20 0.39
BCHE P06276 2/20 0.37
ACHE P22303 2/20 0.37
ALOX5 P09917 1/20 0.37
MEN1 O00255 1/20 0.37
CYP1A2 P05177 1/20 0.37
POLB P06746 1/20 0.37
CYP3A4 P08684 1/20 0.37
ADORA3 P0DMS8 1/20 0.37
ALOX15 P16050 1/20 0.37
ALOX12 P18054 1/20 0.37
CNR1 P21554 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL232686 0.97 GAA (0.54) GAASMN1; SMN2BRPF1MAOAKMT2A
SCHEMBL4571024 0.95 GAA (0.52) GAASMN1; SMN2BRPF1MAOAKMT2A
Sulfuric Acid SCHEMBL8008464 0.85 GAA (0.53) GAASMN1; SMN2BRPF1MAOAKMT2A
Adamantane SCHEMBL3892086 0.85 BRPF1 (0.46) GAASMN1; SMN2BRPF1MAOAKMT2A
Phenazine SCHEMBL9545093 0.85 GAA (0.48) GAASMN1; SMN2BRPF1MAOAKMT2A
SCHEMBL24457996 0.82 ROS1 (0.46) GAASMN1; SMN2BRPF1MAOAKMT2A
SCHEMBL13636983 0.81
SCHEMBL29390564 0.81 MAOA (0.60) GAABRPF1MAOAKMT2AMAPT
SCHEMBL4571020 0.81 MAOA (0.60) GAABRPF1MAOAKMT2AMAPT
SCHEMBL482716 0.81 MAOA (0.60) GAABRPF1MAOAKMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8173803-B2 Supramolecular scaffolds and methods of making the same LOYOLA UNIVERSITY OF CHICAGO (US) 2012-05-08 US disclosed
US-8173803-B2 Supramolecular scaffolds and methods of making the same LOYOLA UNIVERSITY OF CHICAGO (US) 2012-05-08 US disclosed
US-20100041880-A1 Supramolecular Scaffolds and Methods of Making the Same LOYOLA UNIVERSITY OF CHICAGO (US) 2010-02-18 US disclosed
US-20100041880-A1 Supramolecular Scaffolds and Methods of Making the Same LOYOLA UNIVERSITY OF CHICAGO (US) 2010-02-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100041880-A1 Supramolecular Scaffolds and Methods of Making the Same BLM, TBXAS1, TOP2B GAA 3447/4885SMN1; SMN2 2983/4885BRPF1 2256/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.